Journal of Hematology and Oncology Research

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Journal of Hematology and Oncology Research- Liver Disease

USA

Cancer and Genetics Research Complex, University of Florida College of Medicine, 2033 Mowry Road, Room 492-A, Gainesville, FL 32611-3633, USA

Send an Email

Arun Srivastav

Address:

Arun Srivastava, Ph.D. George H. Kitzman Professor of Genetics. Division of Cellular and Molecular Therapy. Departments of Pediatrics and Molecular Genetics & Microbiology. Powell Gene Therapy Center. University of Florida College of Medicine. Gainesville, FL 32611-3633

Research Interests:

Adeno-Associated Viral Gene Therapy, Hematology, Liver Disease.

Biography:

Dr. Srivastava’s research has been focused on the following two parvoviruses, the non-pathogenic adeno-associated virus (AAV), and a common human pathogen, the parvovirus B19, and the development of recombinant parvovirus vectors in human gene therapy. His laboratory has made seminal contributions to the field of parvoviruses, which include: identification of cellular co-receptors for AAV2 and AAV3 as well as parvovirus B19; elucidation of various steps involved in parvovirus trafficking in the cell and nuclear transport; identification of cellular proteins involved in the regulation of AAV DNA replication and encapsidation; development of recombinant AAV and parvovirus B19 vectors; and transgenic and knockout mouse models to study parvovirus-induced pathogenicity, and the use of parvovirus vectors for gene transfer and gene therapy.

Publications:

  • Correction: Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse.
  • Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy.
  • Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy